Therefore, therapeutic strategies, based on manipulation of LRP5 or canonical Wnt signaling, may be effective in targeting both osteoporosis and retinal vascular defects in OPPG patients, with the retinal vasculature being more resistant to potential side effects. This evidence concerns the gene LRP5 and Osteoporosis - pseudoglioma.